# Strength training during GLP-1 treatment: what to keep track of

Weight is one measure. Strength, adequate nutrition and the ability to recover also belong in a GLP-1 treatment review.

Canonical: https://velri.co/blog/strength-training-glp1-protein-resistance-recovery-habits-year-one
Publisher: Velri (https://velri.co/about)
Published: 2026-06-24
Updated: 2026-09-30
Editorial policy: https://velri.co/editorial-policy

During GLP-1 treatment, body weight does not tell the whole story about strength or nutrition. Appetite may decrease, and a treatment review should consider the person's ability to eat adequately, stay active and function well. [1]

## Training is more than a calorie calculation

Muscle-strengthening activity is part of general adult physical-activity guidance, alongside aerobic activity. The CDC recommends activities that work the major muscle groups, with the approach adapted to the person's circumstances. [2]

A useful record can include familiar exercises, repetitions and how demanding the effort feels. That context may reveal a change in function that the scale cannot show.

A harder workout is not automatically a better response to slowing weight loss. Pain, dizziness or a marked decline in ability needs attention rather than being treated as a motivational problem.

## Protein is part of an adequate diet

The International Society of Sports Nutrition describes the complementary roles of protein intake and resistance exercise in supporting muscle protein synthesis. Its guidance concerns exercising populations; it does not establish one protein target for every person receiving a GLP-1 medicine. [3]

Individual needs also depend on overall intake, activity and health conditions. A rigid target copied from an athlete's plan may be inappropriate. Persistent difficulty eating deserves discussion with the treatment team rather than an assumption that lower intake is always beneficial.

## Recovery and side effects belong in the same conversation

Semaglutide's label includes gastrointestinal effects and warns about kidney injury related to dehydration. Repeated vomiting or diarrhea can make normal eating, drinking and activity difficult. [1]

That situation calls for review of the treatment and symptoms, not simply adding supplements or increasing training intensity.

Weight, strength, food tolerance, and recovery describe different parts of the experience. Tracking them together can reveal concerns a weight trend alone would miss.

## Sources
[1] DailyMed - WEGOVY- semaglutide injection, solution
WEGOVY- semaglutide tablet. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
[2] Adult Activity: An Overview | Physical Activity Basics | CDC. https://www.cdc.gov/physical-activity-basics/guidelines/adults.html
[3] International Society of Sports Nutrition Position Stand: protein and exercise | Journal of the International Society of Sports Nutrition | Springer Nature Link. https://jissn.biomedcentral.com/articles/10.1186/s12970-017-0177-8

## About this information
General health information, not personal medical advice, diagnosis or treatment. A prescription is required and is never guaranteed.
Velri is a brand operated by Velri Management LLC, a Nevada limited liability company. Velri is a non-clinical technology and administrative services company. Velri does not provide medical advice, diagnosis, treatment, or pharmacy services, and does not direct the clinical judgment of any provider.
All medical consultations and prescriptions are provided directly by independent provider groups (Online Medical Care, P.C.; TMD of Kansas, P.A.; TMD of Texas, P.A.; and TMD of CA, PC), by a provider licensed in your state. Velri does not employ providers. A prescription is issued only if a provider determines it is clinically appropriate in their independent medical judgment.
All prescription products are dispensed by independent, licensed pharmacies. Velri does not own, operate, or control any pharmacy and does not dispense medication. You may opt out of using a given provider group or pharmacy at any time.
Compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
Velri is cash-pay. We do not bill Medicare, Medicaid, or commercial insurance. Refunds and order problems are addressed in the Terms of Use; your rights under applicable law are not limited. State availability and clinical eligibility apply.
Velri and telehealth are not for medical emergencies. If you are experiencing an emergency, call 911.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Care is available to eligible adults 18 and older in 47 states and D.C., United States only.
Notice of Privacy Practices: https://velri.co/privacy/notice-of-privacy-practices
Terms: https://velri.co/legal/terms
Provider group or pharmacy opt-out help: https://velri.co/contact and https://velri.co/standards#trust-support